Julie A. Stading, PharmD, CDE
Julie A. Stading, PharmD, CDE

Julie A. Stading, PharmD, CDE

Associate Professor
School of Pharmacy and Health Professions

Expertise/Specializations

  • 1992: Clinical Cardiovascular Fellowship

Academic Appointments

Department

  • Pharmacy Practice

Position

  • Associate Professor

Education

  • Creighton University
  • University of Nebraska Lincoln

Certifications

2013-Present APhA Trainer for Diabetes Certificate Program
2008-Present APhA Trainer for Lipid Certificate Program
2004-Present Certified Diabetes Educator

Publications and Presentations

Articles

  • Walter, A. N., Stading, J. A., Qi, Y. Assessment of group-based diabetes education using the 'continuing your journey with diabetes' conversation map in the veteran population, Diabetes Spectrum : A Publication of the American Diabetes Association, 28, 127-131, 2015
  • Stading, JA, Phan, L., Walter, A., Bilslend, L., Qi, YY, et al Initial Experience of Clinical Pharmacy Services Delivered by Computer Communication via Cisco Jabber Video in a US Veterans Administration Medical Center, Journal of Pharmacy Technology, 30, 76-80, 2014
  • Educating community pharmacists about stroke risks and primary prevention, US Pharmacist, 36, 67-77, 2011
  • Chock AWY, O’Brien KK, Stading JA, Shea JL. Educating community pharmacists about stroke risks and primary prevention. US Pharmacist, 2011; 36:67-77., US Pharmacist, 36, 67-77, 2011
  • Stading, J. A., Hermann, J., Walters, R., Destache, C. J., Chock, A. Impact of pharmacist intervention on diabetes patients in an ambulatory setting., Diabetes Spectrum, 22, 241-246, 2009
  • Food and lifestyle interactions with warfarin: a review., US Pharmacist, 34, 28-29, 2009
  • Stading, J. A. Effects of prednisone on the international normalized ratio, American Journal of Health-System Pharmacy, 63, 2354-2356, 2006
  • Chock, A. W. Y., Stading, J. A. Indeterminable International Normalized Ratio with concurrent use of warfarin and gatifloxacin, American Journal of Health-System Pharmacy, 63, 1539-1542, 2006
  • Faulkner, M. A., Lenz, T. L., Stading, J. A. Cost-effectiveness of smoking cessation and implications for COPD, International Journal of COPD, 1, 279-287, 2006
  • Stading, J. A., Chock, A. W., Skrabal, M. Z., Faulkner, M. A. Development of diabetes after gatifloxacin therapy, American Journal of Health-System Pharmacy, 62, 2293-2295, 2005
  • Designing an Assessment for an Abilities-based Curriculum: Process Reliability of the First Two Years., American Journal of Pharmacy Education, 69(article 19), 118-125, 2005
  • Lenz, T. L., Stading, J. A. Lifestyle modification counseling of patients with dyslipidemias by pharmacists and other health care professionals, Journal of the American Pharmaceutical Association, 45, 709-713, 2005
  • Skrabal, M. Z., Stading, J. A., Monaghan, M. S. Rhabdomyolysis associated with simvastatin-nefazodone therapy, Southern Medical Journal, 96, 1034-1035, 2003
  • Skrabal, M. Z., Stading, J. A., Cannella, C. A., Monaghan, M. S. Two cases of rhabdomyolysis associated with high-dose simvastatin, American Journal of Health-System Pharmacy, 60, 578-581, 2003
  • Diabetic Peripheral Neuropathy: Minimizing and Treating Its Pain., US Pharmacist, 27(11), 56-67, 2002
  • Stading, J. A., Skrabal, M. Z., Faulkner, M. A. Seven cases of interaction between warfarin and cyclooxygenase-2 inhibitors, American Journal of Health-System Pharmacy, 58, 2076-2080, 2001
  • Skrabal, M. Z., Stading, J. A., Behmer-Miller, K. A., Hilleman, D. E. Advances in the treatment of congestive heart failure: New approaches for an old disease, Pharmacotherapy, 20, 787-804, 2000
  • Comparative Cost-Effectiveness of Bile Acid Sequestering Resins, HMG Co-A Reductase Inhibitors, and Their Combination in Patients with Hypercholesterolemia,, Journal of Managed Care Pharmacy, 1(Nov/Dec), 188-191, 1995
  • Cost-Minimization Analysis of Initial Antihypertensive Therapy in Patients with Mild to Moderate Hypertension., Clinical Therapeutics, 16(01), 88-102, 1994

Presentations

  • Sero-negative immunization titers for measle-mumps-rubella and hepatitis B in healthcare personnel and subsequent vaccine re-administratoin. Boehme J, Stading J, Schneider A, Bittner M, Qi Y. Poster presented at the national ASHP Midyear Clinical Meeting, Annaheim, CA. Dec 2014., 2014
  • Management of congestive heart failure in the ambulatory care setting. Stading J. Local podium presentation. Lincoln, NE. Aug 9, 2013, 2013
  • Diabetes management in the ambulatory care setting. Stading J. Local podium presentation. Lincoln, NE. July 24, 2013., 2013
  • Diabetes medications, individualizing patient treatment. Stading J. Local podium presentation. Lincoln, NE. May 6, 2013., 2013
  • Assessment of group-based diabetes education using the “continuing your journey with diabetes” conversation map in the veteran population. Walter A, Stading J, Qi Y. Poster presented at the national ASHP Midyear Clinical Meeting. Las Vegas, NV. December 2012, 2012
  • Tobacco cessation. Stading J. Local tobacco cessation class. Lincoln, NE. Weekly starting May 2012., 2012
  • Preparing for a professional interview. Stading J. Local invited presentation at Creighton University to pre-professional students. Omaha, NE. Feb 7, 2012, 2012
  • Diabetes and Native Americans. Stading J. Local invited presentation at Creighton University. Omaha, NE., 2011
  • Diabetes and Native Americans. Stading J. Local invited presentation at Creighton University. Omaha, NE. April, 2011., 2011
  • An overview of diabetes and diabetes medications. Stading J. Local diabetes education class. Lincoln, NE. January, 2011., 2011
  • Impact of pharmacist intervention on monitoring in long term oral amiodarone therapy in the outpatient setting. Stading J, Walters R, Chock A, Kuhlmann V, Messer J. Poster presented at the national ASHP Midyear Clinical Meeting. Anaheim, CA., 2010
  • Update on hyperlipidemia treatments. Stading J. Regional health professionals meeting. Chicago, IL. October 2009, 2009
  • Warfarin resistance in a patient with hyperparathyroidism. Stading J, Chock A, West V. National poster presented at ASHP Midyear Clinical Meeting. Orlando, FL., 2008
  • Atrial fibrillation, an overview of treatment. Stading J. Regional Clinical Pharmacist’s Retreat, Lincoln VAMC, Lincoln, NE., 2008
  • Coagulation cascade: how it all works. Stading J. Regional Clinical Pharmacist’s Retreat. Lincoln VAMC, Lincoln, NE., 2008
  • The Impact of Pharmacist Intervention on Diabetes Patients in an Ambulatory Setting, Stading J, Herrmann J, Destache C, Faulkner M. Poster presented at ACCP Annual Meeting. Denver, CO., 2007
  • Stroke: new trends in pharmacology. Stading JA. State continuing education program for Nebraska Health and Human Services (physicians, pharmacists, nurses). Lincoln, NE., 2007
  • Lipid Management Program (sections: Case 1, Introduction to the Nine Step Process, Case 4 Titrating the Statin Dose, Case 5 Follow-Up Visits, Management of a Clinic). Stading J, Koenigsfeld C, This is a national program sponsored by APhA. Colorado Springs, CO., 2006
  • Effects of bone density screening and individualized education about osteoporosis on patient behavior. Faulkner MA, Ryan-Haddad AM, Coover K, Burns T, Lenz T, Stading J. National poster presented at ASHP Midyear Clinical Meeting. Las Vegas, Nevada, 2005
  • Lipid Management Program (sections: Case 1 with introduction of Nine Step Process, Case 4, Checking lipid levels and Case 5). Stading J, Bradberry C, Shaw B. This is a national program sponsored by APhA to educate pharmacists in lipid management. San Antonio, Texas., 2005
  • Undetermined international normalized ratio and rising prothrombin time with concurrent use of warfarin and gatifloxacin. Chock AW, Stading JA. National poster presentation at American College of Clinical Pharmacists Annual Clinical Meeting, 2005
  • What’s new in smoking cessation. Stading J. Presented at the Alumni and Friends Continuing Education Program Centennial Year Celebration. Omaha, Nebraska., 2005
  • Cost-effectiveness of intensive insulin therapy in critical illness: literature review and meta-analysis. Hilleman DE, Burns TL, Knudsen D, Monaghan MS, Stading JA, Skrabal MZ. American Diabetes Association 65th Annual Meeting, San Diego, California, 2005
  • Use of medications affecting fracture risk in long-term care residents with multiple sclerosis. Faulkner M, Ryan-Haddad A, Lenz T, Stading J. National poster presentation to American Society of Health-System Pharmacist 39th Midyear Clinical Meeting. Orlando, Florida., 2004
  • Volunteer experience at the Nebraska Humane Society: what do pharmacy students learn from animal interactions? Lust E, Galt K, Ohri L, Stading J, Coover K, National poster presentations at Society of Veterinary Hospital Pharmacists, 23rd Annual Meeting, June 2-6, 2004. Virginia Beach, VA and American Association of Colleges of Pharmacy Annual Meeting, Salt Lake City, UT., 2004
  • Pills, Pills, and More Pills – All About Heart Failure Medications, Stading J, Local presentation at BryanLGH Heart Institute, February 25th and 28th, 2004, Lincoln, Nebraska, 2004
  • Effects of Multi-Discipline Educational Forum on Diabetes Patients’ Glycemic Control and Behavior Modification. Stading J, National poster presentation at ASHP Midyear Clinical Meeting, New Orleans, Louisiana, 2003
  • Multidisciplinary Team Taught Educational Session for Diabetes Patients. Stading J, Skrabal M, Faulkner M. National platform presentation at American Society of Health-System Pharmacists Midyear Clinical Meeting in Atlanta, Georgia., 2002
  • Review of New Study: The Essence Study, The Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary Events: A Double Blind, Randomized, Parallel Group, Multicenter Study Comparing Enoxaparin and Intravenous Unfractionated Heparin, Stading J. Local in-service to inpatient pharmacists, St. Joseph Hospital, Omaha, NE., 1996
  • Pharmacologic Stress Testing for the Unstressable, Stading J. continuing education presentation to regional pharmacists, and physicians, Marriot Hotel, Omaha, Nebraska., 1993
  • Arbutamine Stress versus Exercise Stress in Detection of Coronary Artery Disease. & Hypotension During Arbutamine Stress Testing in Healthy Subjects and Patients with Coronary Artery Disease: Clinical Significance? Stading J. Cardiology research conference. Presented to local cardiologists, cardiology fellows, and cardiac nurses, Creighton University Cardiac Center, Omaha, Nebraska., 1993
  • History of Research at Creighton University's Cardiac Center, Stading J. One hundredth anniversary of Creighton University's School of Medicine. Presented to regional alumni of Creighton's School of Medicine, Creighton Cardiac Center, Omaha, Nebraska., 1993
  • Advanced Cardiac Life Support Medications, Stading J. ACLS classes to local hospital staff, St. Joseph Hospital, Omaha, Nebraska,, 1992
  • Effect of Buspirone Symptoms Associated with Smoking Cessation, Stading J. National oral presentation to pharmacists, American Society of Hospital Pharmacists Midyear Clinical Meeting, New Orleans, Louisiana., 1991

Research and Scholarship

Research and Scholarship Interests

  • Cardiology
    Diabetes
    Education

Current Research Projects

  • Resident projects

Grant Funding Received

  • Student/Faculty Research Grant – Diabetes Survey Study Creighton University, $3,000
  • Student/Faculty Research Grant – Diabetes Education Study Creighton University
  • Student/Faculty Research Grant – Amiodarone Review Study Creighton University
  • Continuing Education Grant (unrestricted) GlaxoSmithKline
  • 80+ Hemorrhagic Cohort Study Extension Massachusetts Veterans Epidemiology Research and Information Center, Co-Investigator with M. Skrabal
  • 80+ Hemorrhagic Cohort Study Massachusetts Veterans Epidemiology Research and Information Center, Co-Investigator with M. Skrabal
  • Comparison of the Impact of a Multidisciplinary Educational Program with and without Pharmacy Management with Primary Care Provider Standard Care on the Outcomes of Diabetes Patients Bristol-Meyers-Squibb, $4,000
  • Multidisciplinary Diabetes Management Program at VAMC, Bristol-Meyers-Squibb Co-Investigator with M. Skrabal
  • Impact of Pharmaceutical Counseling on Compliance with Combination Therapy in Patients at High Risk of Recurrent Cardiovascular Events The Upjohn Company, $20,000